Inventor · disambiguated record
Vijay Sidram Benade
Also filed as: BENADE VIJAY · BENADE VIJAY SIDRAM
6 granted patents·4 pending applications·1 citations·filing 2016–2024
66Inventor score
Files withSUVEN LIFE SCIENCES LTD10
Top patents by PatentIndex Score
10 records- 0177US2024277690A1New uses of a 5-ht4 receptor agonistSUVEN LIFE SCIENCES LTD·Filed 2024·Application pending·0 cites
- 0277US2024293389A1Method of treating cognitive deficits associated with schizophreniaSUVEN LIFE SCIENCES LTD·Filed 2024·Application pending·0 cites
- 0375US10294217B2Fluoroindole derivatives as muscarinic M1 receptor positive allosteric modulatorsSUVEN LIFE SCIENCES LTD·Filed 2016·Granted May 21, 2019·1 cites·8 claims
- 0471US12285421B2Uses of a 5-HT4 receptor agonistSUVEN LIFE SCIENCES LTD·Filed 2019·Granted Apr 29, 2025·0 cites·4 claims
- 0563US12338236B2Benzoisothiazole and benzoisoxazole compounds for the treatment of mental disordersSUVEN LIFE SCIENCES LTD·Filed 2023·Granted Jun 24, 2025·0 cites·5 claims
- 0661US12391698B2Substituted piperidines and piperazines and methods for the treatment of CNS disordersSUVEN LIFE SCIENCES LTD·Filed 2023·Granted Aug 19, 2025·0 cites·15 claims
- 0758US12275746B2Pyrrolo[1,2-b]-2-pyridazinone compounds as 5-HT4 receptor agonistsSUVEN LIFE SCIENCES LTD·Filed 2023·Granted Apr 15, 2025·0 cites·7 claims
- 0851US2022409614A1Treating behavioral and psychological symptoms in dementia patientsSUVEN LIFE SCIENCES LTD·Filed 2020·Application pending·0 cites
- 0947US2023000859A1Methods for treating behavioral and psychological symptoms in patients with dementiaSUVEN LIFE SCIENCES LTD·Filed 2020·Application pending·0 cites
- 1042US11622967B2Method of treatment with histamine-3 receptor inverse agonistSUVEN LIFE SCIENCES LTD·Filed 2018·Granted Apr 11, 2023·0 cites·17 claims
Join the waitlist — get patent alerts
Get an alert when Vijay Sidram Benade files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →